Next Article in Journal
Systemic and Mucosal Humoral Immune Response Induced by Three Doses of the BNT162b2 SARS-CoV-2 mRNA Vaccines
Next Article in Special Issue
The Role of CD1 Gene Polymorphism in the Genetic Susceptibility to Spondyloarthropathies in the Moroccan Population and the Possible Cross-Link with Celiac Disease
Previous Article in Journal
Development of Therapeutic Vaccine for Chronic Hepatitis B: Concept, Cellular and Molecular Events, Design, Limitation, and Future Projection
Previous Article in Special Issue
The Interplay of Oxidative Stress and ROS Scavenging: Antioxidants as a Therapeutic Potential in Sepsis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Unravelling the Differential Host Immuno-Inflammatory Responses to Staphylococcus aureus and Escherichia coli Infections in Sepsis

1
Amity Institute of Biotechnology, Amity University Rajasthan, Amity Education Valley, Kant Kalwar, NH-11C, Jaipur-Delhi Highway, Jaipur 303002, Rajasthan, India
2
Department of Biotechnology, University Institute of Biotechnology, Chandigarh University, S.A.S Nagar 140413, Punjab, India
3
Department of Biology, College of Science, University of Ha’il, Ha’il P.O. Box 2440, Saudi Arabia
4
Department of Geriatric Medicine, SMS Medical College & Attached Hospitals, J.L.N. Marg, Jaipur 302004, Rajasthan, India
*
Authors to whom correspondence should be addressed.
Vaccines 2022, 10(10), 1648; https://doi.org/10.3390/vaccines10101648
Submission received: 3 August 2022 / Revised: 27 September 2022 / Accepted: 28 September 2022 / Published: 1 October 2022
(This article belongs to the Special Issue Neutrophils and Host Immunity)

Abstract

:
Previous reports from our lab have documented dysregulated host inflammatory reactions in response to bacterial infections in sepsis. Both Gram-negative bacteria (GNB) and Gram-positive bacteria (GPB) play a significant role in the development and progression of sepsis by releasing several virulence factors. During sepsis, host cells produce a range of inflammatory responses including inducible nitric oxide synthase (iNOS) expression, nitrite generation, neutrophil extracellular traps (NETs) release, and pro-inflammatory cytokines production. The current study was conducted to discern the differences in host inflammatory reactions in response to both Escherichia coli and Staphylococcus aureus along with the organ dysfunction parameters in patients of sepsis. We examined 60 ICU sepsis patients identified based on the Acute Physiology and Chronic Health Evaluation II (APACHE II) and Sequential Organ Failure Assessment (SOFA II) scores. Pathogen identification was carried out using culture-based methods and gene-specific primers by real-time polymerase chain reaction (RT-PCR). Samples of blood from healthy volunteers were spiked with E. coli (GNB) and S. aureus (GPB). The incidence of NETs formation, iNOS expression, total nitrite content, and pro-inflammatory cytokine level was estimated. Prevalence of E. coli, A. baumannii (both GNB), S. aureus, and Enterococcus faecalis (both GPB) was found in sepsis patients. Augmented levels of inflammatory mediators including iNOS expression, total nitrite, the incidence of NETs, and proinflammatory cytokines, during spiking, were found in response to S. aureus infections in comparison with E. coli infections. These inflammatory mediators were found to be positively correlated with organ dysfunction in both GN and GP infections in sepsis patients. Augmented host inflammatory response was generated in S. aureus infections as compared with E. coli.

1. Introduction

Sepsis is an acute, often fatal syndrome that significantly contributes to fatality in the critical care unit and requires early diagnosis along with proper treatment. An inflammatory condition characterized by a dysregulated immune response to infection, sepsis is considered a life-threatening organ malfunction [1]. Gram-negative bacteria (GNB) and gram-positive bacteria (GPB) that have caused underlying infections both affect the severity of sepsis. Since inflammation is the leading cause of the pathogenesis of sepsis, both GNB and GPB conspire to produce different pathologies in this disease [2]. A range of virulence factors are triggered by these pathogens, empowering them to escape the immune defense and propagate to distant organs, releasing certain toxins interacting with host immune cells with particular receptors on the cell surface and producing a poor immune response [3]. The most prevalent bacteria causing sepsis are Staphylococcus aureus, Enterococcus faecalis, Escherichia coli, and Pseudomonas aeruginosa [4].
During the common course of infection, both GPB and GNB bacteria trigger specific signaling pathways [5]. The pathogenicity of GNB is often correlated with some particular components of their membrane, particularly the lipopolysaccharide (LPS), which binds to LPS-binding protein (LBP), enlisting LPS to CD14 [6]. Toll-like receptor-4 (TLR-4) then triggers the signaling pathways of mitogen-activated protein kinase and nuclear factor κB (NF-κB) while communicating with the CD14-LPS complex [7,8]. Similarly, GPB possesses peptidoglycans (PG) and lipoteichoic acids (LTA) as virulence factors that can bind to nucleotide-binding oligomerization domain-containing proteins (NODs), which activate the TLR-2 that recognizes κ-D-glutamyl-meso-diaminopimelic acid, which subsequently activates another signaling pathway by activating NF-κB to induce pro-inflammatory cytokine production [9]. Despite the difference in clinical manifestations of gram-positive (GP) and gram-negative (GN) sepsis, similar therapeutic approaches are used in clinics to treat both pathogens.
Bacterial pore-forming toxins evoke pathophysiologic reactions, leading to differential host immune responses failing in multiple organs. As the first line of defense for the immune system against infection, neutrophils are believed to neutralize pathogens. During such a reaction, neutrophils release granular proteins and chromatin, forming extracellular fibril matrices known as NETs through an active process [10]. During conventional degranulation, cytokines are produced by the rapid secretion of interleukin-4 (IL-4) and tumor necrosis factor α (TNF-α) during exocytosis, resulting in a cytokine storm [11,12,13,14]. In macrophages, increased levels of interferon-γ (IFN-γ) promote the production of iNOS [15]. Excessive synthesis of inflammatory mediators causes the formation of reactive oxygen and nitrogen species, such as superoxide anion (O2.-) and nitric oxide (NO), resulting in the injury of tissues with increased inflammatory response. The function of oxidative stress [16], nitrosative stress [17], and hyper NETs production [18] in multiple organ dysfunctions during sepsis has been documented in previous papers from our lab. Due to the difference in induction of signaling pathways by GNB and GPB, the amount of inflammatory response would be different [1].
The current study was conducted to discern host inflammatory reactions in response to both S. aureus and E. coli bacterial infections. Herein, we determined the levels of inflammatory mediators including NOS expression, nitrite content, NETs release, and pro-inflammatory cytokines in S. aureus and E. coli bacteria-infected blood. Furthermore, different organ dysfunction parameters were evaluated in both S. aureus and E. coli infections in sepsis patients.

2. Materials and Methods

2.1. Patients Selection

Patients fulfilling the criteria of sepsis [19] were enlisted for the survey. Written and informed consent either from patients or their relatives, and ethical permission from SMS Hospital as well as Amity University Rajasthan, Jaipur (Reference number AUR/IEC/2019/01) was taken prior to initiation of the study. Patients were chosen based on (i) medical evidence of infection, (ii) hyperthermia (higher body temperature i.e., >38 °C) or hypothermia (lower body temperature i.e., <35 °C), (iii) tachycardia (elevated heart rate (>100 beats per minute), (iv) tachypnea (accelerated breathing i.e., >30 breaths per minute), and (v) evidence of poor organ function or perfusion within 12 h. Patients aged 80 years or more, also with (i) heart failure (class III or IV), (ii) hepatic insufficiency, (iv) immunosuppression (positive HIV, HBs Ag virus serologic result, malignancy), and (v) chronic antibiotic therapy were all excluded. Upon admittance to the ICU (Intensive care Unit), each patient’s clinical and demographic characteristics were recorded independently, including temperature (°C), heart rate, respiration rate, mean arterial pressure, SOFA (Sequential Organ Failure Assessment), APACHE II (Acute Physiology and Chronic Health Evaluation II), total bilirubin, creatinine, and PaO2/FiO2 ratio.

2.2. Blood Sample Collection

Serial blood specimens (10 mL of blood) were collected from the central venous line in ethylene diamine tetra acetic acid (EDTA) vials at the time of admission.

2.3. Blood Culture

Post blood sample collection, culture was performed using a BACTEC (BD, Heidelberg, Germany) blood culture system at 37 °C. The culture vials that showed growth within five days of culture incubation were separated from those that did not show growth. The growth of bacteria from liquid broth was subcultured on standardized and selected media, including blood agar, chocolate agar, and MacConkey agar, and the results were studied after 24–48 h of incubation. Standard microbiological procedures, such as Gram staining, colony features, and biochemical properties, such as catalase and coagulase, were used to examine the results, which were validated using standard manuals [20].

2.4. Bacterial Identification by RT-PCR

Identification of the most prevalent GNB (E. coli) and GPB (S. aureus) was done by real-time PCR (RT-PCR). Bacterial DNA was separated from whole blood using a standard kit (Nucleo-Spin® Blood Quick Pure) as per the manufacturer’s instructions and used as a template for RT-PCR, which was done using gene-specific primers for E. coli (16s rRNA gene) and S. aureus (16S rRNA gene). DNA was amplified by PCR (Bio-Rad, Hercules, CA, USA), using Primer3 (http://frodo.wi.mit.edu/, accessed on 1 August 2022), a specialized web-based program, to design the primers. The primers used to amplify the E. coli 16s rRNA gene were F: 5′TGGCGCATACAAAGAGAAGC3′ and R: 5′TTTTGCAACCCACTCCCATG3′ and to amplify S. aureus 16S rRNA gene were F: 5′GAACCGCATGGTTCAAAAGT3′ and R: 5′CGGAAGATTCCCTACTGCTG3′ which amplified a 192 bp and 191 bp products, respectively. The iTaq Universal SYBR Green RT-PCR master mix was used for real-time PCR. Reactions of a total volume of 20 µL included 10 µL of iTaq Universal SYBR Green Supermix, 50 ng of DNA template, and 0.5 µL of primers. The three-step PCR procedure consisted of 2 min at 95 °C, 40 cycles of denaturation at 95 °C for 30 s, the ideal annealing 56.4 °C for E. coli and 59.4 °C for S. aureus, extension at 72 °C for 1 min, and a final extension at 72 °C for 2 min. To ensure the specificity of the PCR result as a single peak, a melting curve was run at the end of the PCR.

2.5. Isolation of Neutrophils from Blood

Platelets were removed from the blood by centrifuging at 200× g for 10 min to isolate neutrophils. After that, another 10 min of centrifugation at 700× g was performed. In a separate tube, white blood cells were collected from a buffy coat layer and dextran sedimented for 30 min at room temperature. Platelet-deficient plasma was kept at −20 °C for nitrite and cytokines measurement. The supernatant (4 mL) was transferred to 4 mL Percoll (1065/1080, same volume) and centrifuged at 700× g for 15 min at room temperature. The supernatant was removed, and the neutrophil-containing band was collected and resuspended in RPMI 1640 medium supplemented with bovine serum albumin (2%). Further neutrophils were washed with Hanks’ Balanced Salt Solution (HBSS) (NaCl 138 mM; KCl 2.7 mM; Na2HPO4 8.1 mM; KH2PO4 1.5 mM; Glucose 10 mM). The purity of the population was ascertained by Giemsa staining and viability by Trypan blue exclusion assay, with the results showing the population as 99% pure and viable.

2.6. Spiking

The pure culture of E. coli (ATCC E. coli 25922) and S. aureus (ATCC S. aureus 29213) have been taken from SMS Hospital, Jaipur. Cultures of S. aureus and E. coli were maintained in Luria–Bertani (LB) broth incubated overnight in 100 mL of nutritional broth at 37 °C. The bacteria were then diluted to a final concentration of 108 cells per ml using absorbance at 600 nm wavelength [21]. Neutrophils were infected with both the bacteria with the multiplicity of infection 10 for 1 h [22].

2.7. iNOS Expression

For iNOS expression analysis, neutrophils were spiked with 200 μL of the culture of E. coli and S. aureus (McFarland 0.5) followed by incubation at 37 °C for 1 h. Total RNA from neutrophils (106 cells) was isolated using a Tri reagent (Sigma, St. Louis, MI, USA). First, using a Revert Aid H Minus First Strand cDNA Synthesis Kit (Thermo Scientific, Madison, WI, USA) and oligo (dT) primer as directed by the manufacturer, 1 g of total RNA was reverse transcribed. The cDNA was transcribed with primers for iNOS (F: 5′TGTGCTCTTTGCCTGTATGC3′; R-5TTGCCAAACGTACTG GTCAC3′) and β-actin (F: 5′AACTGGAACGGTGAAGGTG3′; R: 5′CTGTGTGGACTTGGGAGAGG3) with the amplified products of 222 bp and 210 bp products, respectively. iNOS mRNA was quantified by RT- PCR (Bio-Rad, Hercules, CA, USA) using an iTaq Universal SYBR Green RT-PCR master mix and the same primers and cDNA as mentioned previously. Following PCR, amplicons were held at 70 °C for 10 s before being melted at 90 °C at a temperature rate of 0.1 °C per second for melting curve analysis. One melting curve cycle included 95°C for 15 s, 70 °C for 15 s, 95 °C for 10 s, and 40 °C for 3 min of cooling. As a single peak, this indicated the specificity of the PCR result. The experiment contained a control for all reaction components except the template. The reference gene β-actin was used for normalization. The difference in β-actin and iNOS quantification cycle values was used to determine the expression level of iNOS.

2.8. Total Nitrite Assay

The nitrite content in supernatant collected from neutrophils spiked with E. coli and S. aureus was determined by a Griess reagent kit (Thermo Fischer Scientific, Waltham, MA, USA) according to the instructions given in the manufacturer’s protocol.

2.9. NETs Release

NETs were generated following the protocol described previously, with modification [18,23,24]. A total of 106 cells/mL of neutrophils isolated from healthy volunteers were adhered on poly-L-lysine coated petri plates, followed by washing with HBSS and treating with E. coli and S. aureus for 30 min. 4% Paraformaldehyde was used for 30 min to fix the cells, and stained with elastase antibody (1:250 dilutions) overnight. Cells were washed five times with HBSS and stained with antirabbit alexa fluor 647 antibody (1:5000 dilutions) for 4 h at room temperature in the dark. This was washed five times with HBSS. Sytox green was added and incubated for 15 min before being examined under a fluorescence microscope (Leica). Unstimulated cells were used as the negative control. The percentage of NETs was evaluated by counting the number of NETs formed by neutrophils out of the total number of neutrophils, as observed in a field in a fluorescence microscope [18,25].

2.10. Cytokines Estimation

Levels of TNF-α, IFN-γ, and IL-8 were estimated in supernatant collected from spiked neutrophils with E. coli and S. aureus using an ELISA kit as determined by the protocol of the manufacturer (BD Opt EIA, East Rutherford, New Jersey, USA).

2.11. Statistical Analysis after the Estimation of Total Nitrite Assay and Cytokine

The data were analyzed with the SPSS program (SPSS Inc., Chicago, IL, USA) and reported as means + standard deviation from four independent experiments. The significance of the results was considered at p < 0.05.

3. Results

3.1. Detection of Pathogens by Blood Culture and RT-PCR

The classification of Sepsis-3 is used to depict the study of population quality [21] as shown in Table 1. A total of 60 patients (average age 49.11 years; 37 males, 23 females) with sepsis were enrolled. Bacteria were detected and identified by the biochemical test. RT-PCR was done to detect the most prevalent GNB (E. coli) and GPB (S. aureus). Out of 60 cases, 39 (65%) were GP and 21 (35%) were GN (Figure 1A). Among GNB, E. coli (47%) P. aeruginosa (14%) A. baumannii (9%), K. pneumoniae (19%) and S. Typhi (9%) were prevalent (Figure 1B). S. aureus (51%) E. faecalis (23%), S. haemolyticus (12%), and S. hominis (12%) were predominant among GPB (Figure 1C). E. coli (GN) and S. aureus (GP) were responsible for most of the infections.

3.2. Expression of iNOS Generation and Estimation of Total Nitrite Content

Inflammatory reactions in response to E. coli and S. aureus infection were monitored in spiked neutrophils isolated from a healthy volunteer. Augmented expression of iNOS (p < 0.01) was found in S. aureus-spiked neutrophils as compared with E. coli-infected neutrophils, as demonstrated by RT-PCR (Figure 2A). Nitrite, a stable product of NO generated in the supernatant due to induction of inflammatory response, is increased in S. aureus infection (65 ± 2.1 µ mol/L versus 43 ± 1.4 µmol/L, p < 0.01) (Figure 2B).

3.3. NETs Formation and Estimation of Cytokines

In neutrophils, the prevalence of NETs was measured and compared in E. coli and S. aureus using confocal microscopy. A greater increase in the incidence of NETs was found in response to S. aureus than E. coli (81 ± 4.2% versus 64 ± 1.7%, p < 0.01) (Figure 3A,B).
The cell-free content of proinflammatory cytokines was estimated using ELISA in supernatant separated from neutrophils after spiking with S. aureus and E. coli. Levels of TNF-α (164 ± 8.3 pg/mL versus 123 ± 3.4 pg/mL, p < 0.001), IL-1β (65 ± 3.3 pg/mL versus 38 ± 2.7 pg/mL, p < 0.001), IL-8 (173 ± 6.3 pg/mL versus 129 ± 8.4 pg/mL, p < 0.001) were found to be augmented in S. aureus infection as compared with E. coli infection (Figure 3C). The level of cytokines is less than 10 pg/mL in supernatant without bacteria presented. Our data are in accordance with a previous report which documented an almost two-fold greater amount of TNF-α generated by human monocytes in response to S. aureus infections than E. coli [26].

3.4. Estimation of Organ Dysfunction

The level of organ dysfunction parameters and organ-specific dysfunction markers were evaluated and compared in the GPB and GNB group of patients. We found a higher level of SOFA (8.2 ± 1.7 versus 6.1 ± 1.4) (Figure 4A) and APACHE II score (21.2 ± 3.7 versus 19.1 ± 2.9) (Figure 4B) in the GPB group in comparison with the GNB group. The total bilirubin, which assesses the hepatotoxicity, was slightly higher in the GPB group compared with the GNB group (31.2 ± 5.7µmol/L versus 28.1 ± 4.4µmol/L) (Figure 4C). The creatinine level, a potent marker of kidney function, was found to be higher in the GPB group compared with the GNB group (198.5 ± 5.3µmol/Lversus185.2 ± 6.1µmol/L) (Figure 4D). The PaO2/FIO2 ratio, which measures the lung function, was lower in the GPB group compared with the GNB group (216.4 ± 24.2µmol/L versus 296.5 ± 22.1 µmol/L) (Figure 4D).

4. Discussion

The purpose of this study was to investigate the detection of pathogens by RT-PCR and blood culture. We found that S. aureus bacteremia is a frequent clinical problem in most medical centers and is linked with high morbidity and mortality. Data showing a higher prevalence of S. aureus over E. coli are in agreement with a previous study, where 46% of isolates were GPB and 20% were GNB [27]. Similar trends were found in other reports [28], and few studies documented contrasting results with a greater occurrence of E. coli over S. aureus [29]. The possible explanation for the difference could be the design, geographic location, nature of difference of the etiological agents, and seasonal variation. S. aureus lives on human body surfaces and colonizes intravenous catheters, which become a source of infection in hospitalized patients, especially those with impaired immune systems, and leads to septicemia. In severe infections, S. aureus and E. coli damage internal organs including the brain, heart, lungs, as well as bones, muscles, and surgically implanted devices such as artificial joints or cardiac pacemakers [30].
We also contemplated nitrosative stress (iNOS expression /NO content/total nitrite) and pro-inflammatory cytokines (TNF-α, IFN-γ, and IL8) related to S. aureus and E. coli bacteria severity. Our PCR analysis and computational studies revealed an enhancement of iNOS in GPB (S. aureus) cases compared to GNB (E. coli). This might be related to the presence of LTA, which causes shock and multiple organ failure by activating tyrosine kinases and NF-kB in the signaling pathway, triggering the induction of iNOS [31]. In addition, macrophage-inducing iNOS is significant in the host defense system, as it stimulates NO production, which adds to bactericidal effects [32]. Similarly, LPS is required for iNOS induction, which activates certain cytokines such as IFN-γ and migration inhibitory factor that can activate macrophages to produce NO [33].
Our evidence of increased NO production adds to our understanding of the underlying cause for higher nitrite content that could be due to the presence of LTA and peptidoglycan over the cell wall of S. aureus, which has been shown to induce the formation of NO, followed by shock and organ injury in rats [9]. When NO, a precursor of nitrite, reacts with superoxide to form peroxynitrite, a potent oxidant, it causes cytotoxicity [34,35], thereby producing nitrous and nitric acids (NO2/NO3) in an aqueous solution, which are important signaling molecules with regulatory properties that can influence the course of inflammation and immunological regulation [36]. Our results suggest that the increased frequency of NETs is because neutrophils were already primed while spiking the blood with S. aureus and E. coli. The cell wall component of gram-positive bacteria, LTA, is a known chemo-attractant for neutrophils that helps in priming and recruitment of neutrophils at the site of inflammation [37]. Furthermore, rapid NETs release has been documented in response to S. aureus infection due to TLR2 and complement-mediated opsonization [38].
In sepsis, pro-inflammatory cytokines released by neutrophils and monocytes can better determine the severity of infection [39,40]. Furthermore, the correlation between increased cytokine levels in our study was conducted using a spiked neutrophil model, where the level of IFN-γ, a pro-inflammatory cytokine, was found to be upregulated in S. aureus septicemia as compared with E. coli septicemia. Contrary to our results, increased TNF-α and IL-8 were released with E. coli compared with S. aureus. The major reason behind this discrepancy could be that it includes patients with severe abdominal sepsis who harbor different pathogens involved in the immunological response [41].
We also acknowledge organ dysfunction where the above data suggest that S. aureus infection causes more damage to the organs as compared with E. coli. The possible reason could be hyperactivation of inflammatory responses including aberrant oxidative stress [16], nitrosative stress [17], and NETs release [18], which induces multiple organ dysfunction as S. aureus evokes more inflammatory response than E. coli as we found in the current study. Mechanistically, the physical interaction of iNOS and the Rac2 protein plays an important role in hyper inflammation-induced cytotoxicity in lung epithelial cells [42].

5. Conclusions

In summary, we found an increased prevalence of GP infections (S. aureus) as compared with GN (E. coli) during sepsis. In the whole blood spiking model, S. aureus evoked a greater inflammatory response (iNOS expression, total nitrite content, NETs release, and pro-inflammatory cytokine production) than E. coli. Thus, these inflammatory mediators have the potential to discriminate between GP and GN infections, thus bearing prognostic value. Additionally, we also found increased levels of host organ dysfunction in GPB infections than GNB infections during sepsis (Figure 5). The major limitation in our study is that data obtained from a singly type of bacteria cannot be generalized for all the GNB and GPB groups.

Author Contributions

Conceptualization, E.G., S.K. (Sanni Kumar) and A.J.; methodology, E.G., S.K. (Sanni Kumar) and S.M.; formal analysis, E.G., S.K. (Sanni Kumar), V.K.S., J.S., A.J.S. and S.K. (Sanket Kaushik); writing—E.G. and S.K. (Sanni Kumar); original draft preparation, E.G. and S.K. (Sanni Kumar); writing—E.G., S.K. (Sanni Kumar) and A.J; supervision, A.J. All authors have read and agreed to the published version of the manuscript.

Funding

Financial support from the Indian Council of Medical Research, New Delhi, India (2019-5517/CMB-BMS) is acknowledged.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Ethics Committee of SMS Hospital as well as Amity University Rajasthan, Jaipur (Reference number AUR/IEC/2019/01) for studies involving humans.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Raw data included in the manuscript is available and can be shared if required.

Conflicts of Interest

Authors declare no conflict of interest.

References

  1. Dickson, K.; Lehmann, C. Inflammatory response to different toxins in experimental sepsis models. Int. J. Mol. Sci. 2019, 20, 4341. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Minasyan, H. Sepsis and septic shock: Pathogenesis and treatment perspectives. J. Crit. Care 2017, 40, 229–242. [Google Scholar] [CrossRef] [PubMed]
  3. Tunjungputri, R.N.; van de Heijden, W.; Urbanus, R.T.; de Groot, P.G.; van der Ven, A.; de Mast, Q. Higher platelet reactivity and platelet-monocyte complex formation in Gram-positive sepsis compared to Gram-negative sepsis. Platelets 2017, 28, 595–601. [Google Scholar] [CrossRef] [PubMed]
  4. Abe, T.; Ogura, H.; Kushimoto, S.; Shiraishi, A.; Sugiyama, T.; Deshpande, G.A.; Uchida, M.; Nagata, I.; Saitoh, D.; Fujishima, S.; et al. Variations in infection sites and mortality rates among patients in intensive care units with severe sepsis and septic shock in Japan. J. Intensive Care 2019, 7, 1–9. [Google Scholar] [CrossRef] [Green Version]
  5. Pfalzgraff, A.; Weindl, G. Intracellular lipopolysaccharide sensing as a potential therapeutic target for sepsis. Trends Pharmacol. Sci. 2019, 40, 187–197. [Google Scholar] [CrossRef]
  6. Mallat, J.; Leone, S.; Cascella, M.; Fiore, M. Should endotoxin be a research priority in Gram-negative sepsis and septic shock? Expert Rev. Clin. Pharmacol. 2019, 12, 697–699. [Google Scholar] [CrossRef] [Green Version]
  7. Danielski, L.G.; Giustina, A.D.; Bonfante, S.; Barichello, T.; Petronilho, F. The NLRP3 inflammasome and its role in sepsis development. Inflammation 2020, 43, 24–31. [Google Scholar] [CrossRef]
  8. Chen, F.; Zou, L.; Williams, B.; Chao, W. Targeting toll-like receptors in sepsis: From bench to clinical trials. Antioxid. Redox Signal. 2021, 35, 1324–1339. [Google Scholar] [CrossRef]
  9. Leung, A.K.; Genga, K.R.; Topchiy, E.; Cirstea, M.; Shimada, T.; Fjell, C.; Russell, J.A.; Boyd, J.H.; Walley, K.R. Reduced Proprotein convertase subtilisin/kexin 9 (PCSK9) function increases lipoteichoic acid clearance and improves outcomes in Gram positive septic shock patients. Sci. Rep. 2019, 9, 10588. [Google Scholar] [CrossRef] [Green Version]
  10. Bühler, T.; Boos, N.; Leuppi-Taegtmeyer, A.B.; Berger, C.T. Febrile illness and bicytopenia within hours after tick-borne encephalitis booster vaccination. NPJ Vaccines 2019, 4, 52. [Google Scholar] [CrossRef] [Green Version]
  11. Chousterman, B.G.; Swirski, F.K.; Weber, G.F. Cytokine storm and sepsis disease pathogenesis. Semin. Immunopathol. 2017, 39, 517–528. [Google Scholar] [CrossRef] [PubMed]
  12. Cron, R.Q.; Behrens, E.M. (Eds.) Cytokine Storm Syndrome; Springer Nature: Berlin/Heidelberg, Germany, 2019. [Google Scholar]
  13. Cabrera, C.P.; Manson, J.; Shepherd, J.M.; Torrance, H.D.; Watson, D.; Longhi, M.P.; Hoti, M.; Patel, M.B.; O’Dwyer, M.; Nourshargh, S.; et al. Signatures of inflammation and impending multiple organ dysfunction in the hyperacute phase of trauma: A prospective cohort study. PLoS Med. 2017, 14, e1002352. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Margraf, A.; Ludwig, N.; Zarbock, A.; Rossaint, J. Systemic inflammatory response syndrome after surgery: Mechanisms and protection. Anesth. Analg. 2020, 131, 1693–1707. [Google Scholar] [CrossRef]
  15. Sonar, S.A.; Lal, G. The iNOS activity during an immune response controls the CNS pathology in experimental autoimmune encephalomyelitis. Front. Immunol. 2019, 10, 710. [Google Scholar] [CrossRef] [Green Version]
  16. Kumar, S.; Gupta, E.; Kaushik, S.; Kumar Srivastava, V.; Mehta, S.; Jyoti, A. Evaluation of oxidative stress and antioxidant status: Correlation with the severity of sepsis. Scand. J. Immunol. 2018, 87, e12653. [Google Scholar] [CrossRef] [Green Version]
  17. Kumar, S.; Gupta, E.; Srivastava, V.K.; Kaushik, S.; Saxena, J.; Goyal, L.K.; Mehta, S.; Jyoti, A. Nitrosative stress and cytokines are linked with the severity of sepsis and organ dysfunction. Br. J. Biomed. Sci. 2019, 76, 29–34. [Google Scholar] [CrossRef] [PubMed]
  18. Kumar, S.; Gupta, E.; Kaushik, S.; Kumar Srivastava, V.; Mehta, S.; Jyoti, A. Quantification of NETs formation in neutrophil and its correlation with the severity of sepsis and organ dysfunction. Clin. Chim. Acta 2019, 495, 606–610. [Google Scholar] [CrossRef]
  19. Gül, F.; Arslantaş, M.K.; Cinel, İ.; Kumar, A. Changing definitions of sepsis. Turk. J. Anaesthesiol. Reanim. 2017, 45, 129. [Google Scholar] [CrossRef]
  20. Dong, M.; Fisher, C.; Añez, G.; Rios, M.; Nakhasi, H.L.; Hobson, J.P.; Beanan, M.; Hockman, D.; Grigorenko, E.; Duncan, R. Standardized methods to generate mock (spiked) clinical specimens by spiking blood or plasma with cultured pathogens. J. Appl. Microbiol. 2016, 120, 1119–1129. [Google Scholar] [CrossRef] [Green Version]
  21. Keshari, R.S.; Jyoti, A.; Dubey, M.; Kothari, N.; Kohli, M.; Bogra, J.; Barthwal, M.K.; Dikshit, M. Cytokines induced neutrophil extracellular traps formation: Implication for the inflammatory disease condition. PLoS ONE 2012, 7, e48111. [Google Scholar] [CrossRef] [Green Version]
  22. Wan, T.; Zhao, Y.; Fan, F.; Hu, R.; Jin, X. Dexamethasone inhibits S. aureus-induced neutrophil extracellular pathogen-killing mechanism, possibly through toll-like receptor regulation. Front. Immunol. 2017, 8, 60. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Sharma, A.; McCann, K.; Tripathi, J.K.; Chauhan, P.; Zerbe, C.; Mishra, B.B.; Holland, S.M.; Sharma, J. Tamoxifen restores extracellular trap formation in neutrophils from patients with chronic granulomatous disease in a reactive oxygen species–independent manner. J. Allergy Clin. Immunol. 2019, 144, 597–600. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Tripathi, J.K.; Sharma, A.; Sukumaran, P.; Sun, Y.; Mishra, B.B.; Singh, B.B.; Sharma, J. Oxidant sensor cation channel TRPM2 regulates neutrophil extracellular trap formation and protects against pneumoseptic bacterial infection. FASEB J. 2018, 32, 6848–6859. [Google Scholar] [CrossRef]
  25. Idelevich, E.A.; Storck, L.M.; Sparbier, K.; Drews, O.; Kostrzewa, M.; Becker, K. Rapid direct susceptibility testing from positive blood cultures by the matrix-assisted laser desorption ionization–time of flight mass spectrometry-based direct-on-target microdroplet growth assay. J. Clin. Microbiol. 2018, 56, e00913-18. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Hessle, C.C.; Andersson, B.; Wold, A.E. Gram-positive and Gram-negative bacteria elicit different patterns of pro-inflammatory cytokines in human monocytes. Cytokine 2005, 30, 311–318. [Google Scholar] [CrossRef] [PubMed]
  27. Zhang, Z.; Chen, M.; Yu, Y.; Pan, S.; Liu, Y. Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012–2016 as part of the Tigecycline Evaluation and Surveillance Trial. Antimicrob. Resist. Infect. Control 2018, 7, 152. [Google Scholar] [CrossRef]
  28. Gao, L.; Liu, X.; Zhang, D.; Xu, F.; Chen, Q.; Hong, Y.; Feng, G.; Shi, Q.; Yang, B.; Xu, L. Early diagnosis of bacterial infection in patients with septicopyemia by laboratory analysis of PCT, CRP and IL-6. Exp. Ther. Med. 2017, 13, 3479–3483. [Google Scholar] [CrossRef] [Green Version]
  29. Thomas-Rüddel, D.O.; Poidinger, B.; Kott, M.; Weiss, M.; Reinhart, K.; Bloos, F. Influence of pathogen and focus of infection on procalcitonin values in sepsis patients with bacteremia or candidemia. Crit. Care 2018, 22, 128. [Google Scholar] [CrossRef] [Green Version]
  30. Kwiecinski, J.M.; Horswill, A.R. Staphylococcus aureus bloodstream infections: Pathogenesis and regulatory mechanisms. Curr. Opin. Microbiol. 2020, 53, 51–60. [Google Scholar] [CrossRef]
  31. Lee, E.J.; Park, J.S.; Lee, Y.Y.; Kim, D.Y.; Kang, J.L.; Kim, H.S. Anti-inflammatory and anti-oxidant mechanisms of an MMP-8 inhibitor in lipoteichoic acid-stimulated rat primary astrocytes: Involvement of NF-κB, Nrf2, and PPAR-γ signaling pathways. J. Neuroinflamm. 2018, 15, 326. [Google Scholar] [CrossRef] [Green Version]
  32. Spiller, F.; Formiga, R.O.; da Silva Coimbra, J.F.; Alves-Filho, J.C.; Cunha, T.M.; Cunha, F.Q. Targeting nitric oxide as a key modulator of sepsis, arthritis and pain. Nitric Oxide 2019, 89, 32–40. [Google Scholar] [CrossRef] [PubMed]
  33. Hung, Y.L.; Suzuki, K. The pattern recognition receptors and lipopolysaccharides (LPS)-induced systemic inflammation. Int. J. Res. Stud. Med. Health Sci. 2017, 2, 1–7. [Google Scholar]
  34. Tallam, A.; Perumal, T.M.; Antony, P.M.; Jäger, C.; Fritz, J.V.; Vallar, L.; Balling, R.; Del Sol, A.; Michelucci, A. Gene regulatory network inference of immunoresponsive gene 1 (IRG1) identifies interferon regulatory factor 1 (IRF1) as its transcriptional regulator in mammalian macrophages. PLoS ONE 2016, 1, e0149050. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Bogdan, C. Nitric oxide synthase in innate and adaptive immunity: An update. Trends Immunol. 2015, 36, 161–178. [Google Scholar] [CrossRef]
  36. Winkler, M.S.; Kluge, S.; Holzmann, M.; Moritzm, E.; Robbe, L.; Bauer, A.; Zahrte, C.; Priefler, M.; Schwedhelm, E.; Böger, R.H.; et al. Markers of nitric oxide are associated with sepsis severity: An observational study. Crit. Care 2017, 21, 189. [Google Scholar] [CrossRef] [Green Version]
  37. Shaker, N.B.; Ali, K.O. Role of IL-6 and IL-10 as biomarkers in diagnosis of bacteremia in hemodialysis patients. Al-Kufa Univ. J. Biol. 2019, 11, 34–41. [Google Scholar]
  38. Jorch, S.K.; Kubes, P. An emerging role for neutrophil extracellular traps in noninfectious disease. Nat. Med. 2017, 23, 279–287. [Google Scholar] [CrossRef]
  39. Chaudhry, H.; Zhou, J.; Zhong, Y.I.; Ali, M.M.; McGuire, F.; Nagarkatti, P.S.; Nagarkatti, M. Role of cytokines as a double-edged sword in sepsis. In Vivo 2013, 27, 669–684. [Google Scholar]
  40. Black, L.P.; Puskarich, M.A.; Henson, M.; Miller, T.; Reddy, S.T.; Fernandez, R.; Guirgis, F.W. Quantitative and qualitative assessments of cholesterol association with bacterial infection type in sepsis and septic shock. J. Intensive Care Med. 2021, 36, 808–817. [Google Scholar] [CrossRef]
  41. Surbatovic, M.; Popovic, N.; Vojvodic, D.; Milosevic, I.; Acimovic, G.; Stojicic, M.; Veljovic, M.; Jevdjic, J.; Djordjevic, D.; Radakovic, S. Cytokine profile in severe Gram-positive and Gram-negative abdominal sepsis. Sci. Rep. 2015, 5, 11355. [Google Scholar] [CrossRef] [Green Version]
  42. Kumar, S.; Gupta, E.; Kaushik, S.; Kumar Srivastava, V.; Mehta, S.; Jyoti, A. Functional role of iNOS-Rac2 interaction in neutrophil extracellular traps (NETs) induced cytotoxicity in sepsis. Clin. Chim. Acta 2021, 513, 43–49. [Google Scholar] [CrossRef] [PubMed]
Figure 1. (A) Pie chart showing the percentage of GNB and GPB present out of the total cases. (B) Pie chart showing the percentage of GNB E. coli, P. aeruginosa, A. baumannii, K. pneumoniae, and S. typhimurium. (C) Pie chart showing the percentage of GPB S. aureus, E. faecalis, S. haemolyticus, and S. hominis.
Figure 1. (A) Pie chart showing the percentage of GNB and GPB present out of the total cases. (B) Pie chart showing the percentage of GNB E. coli, P. aeruginosa, A. baumannii, K. pneumoniae, and S. typhimurium. (C) Pie chart showing the percentage of GPB S. aureus, E. faecalis, S. haemolyticus, and S. hominis.
Vaccines 10 01648 g001
Figure 2. (A) Bar diagrams showing the RT-PCR-based relative expression of iNOS in human neutrophils spiked with E. coli and S. aureus (** p < 0.01). (B) Bar diagrams showing total nitrite content in the culture supernatant of neutrophils spiked with E. coli and S. aureus (** p < 0.01).
Figure 2. (A) Bar diagrams showing the RT-PCR-based relative expression of iNOS in human neutrophils spiked with E. coli and S. aureus (** p < 0.01). (B) Bar diagrams showing total nitrite content in the culture supernatant of neutrophils spiked with E. coli and S. aureus (** p < 0.01).
Vaccines 10 01648 g002
Figure 3. (A) Confocal images showing the formation of NETs in control (top panel), E. coli (middle panel), and S. aureus (bottom panel) spiked neutrophils. i, iv, and vii are merged images of neutrophils stained with SYTOX green and elastase antibody conjugated with Alexa flour 647. ii, v, and viii are the images of neutrophils stained with elastase antibody conjugated with Alexa flour 647. iii, vi, and ix are the images of neutrophils stained with SYTOX green. The scale represents 50 μm. The images are representatives of three independent experiments. (B) Bar diagrams representing percent incidence of NETs release measured in neutrophils spiked with E. coli and S. aureus (** p < 0.01). (C) Bar diagrams representing the level of cytokines (TNF-α, IL-1β, IL-8) in the culture supernatant of neutrophils spiked with E. coli and S. aureus (*** p < 0.001).
Figure 3. (A) Confocal images showing the formation of NETs in control (top panel), E. coli (middle panel), and S. aureus (bottom panel) spiked neutrophils. i, iv, and vii are merged images of neutrophils stained with SYTOX green and elastase antibody conjugated with Alexa flour 647. ii, v, and viii are the images of neutrophils stained with elastase antibody conjugated with Alexa flour 647. iii, vi, and ix are the images of neutrophils stained with SYTOX green. The scale represents 50 μm. The images are representatives of three independent experiments. (B) Bar diagrams representing percent incidence of NETs release measured in neutrophils spiked with E. coli and S. aureus (** p < 0.01). (C) Bar diagrams representing the level of cytokines (TNF-α, IL-1β, IL-8) in the culture supernatant of neutrophils spiked with E. coli and S. aureus (*** p < 0.001).
Vaccines 10 01648 g003aVaccines 10 01648 g003b
Figure 4. (A) Bar diagrams representing the SOFA score in the GPB and GNB groups (B) Bar diagrams representing the APACHE II score in the GPB and GNB groups (C) Bar diagrams representing the total bilirubin content in the GPB and GNB groups groups. (D) Bar diagrams representing the creatinine in the S. aureus and E. coli. (E) Bar diagrams representing the PaO2/ FIO2 ratio in the GPB and GNB groups.
Figure 4. (A) Bar diagrams representing the SOFA score in the GPB and GNB groups (B) Bar diagrams representing the APACHE II score in the GPB and GNB groups (C) Bar diagrams representing the total bilirubin content in the GPB and GNB groups groups. (D) Bar diagrams representing the creatinine in the S. aureus and E. coli. (E) Bar diagrams representing the PaO2/ FIO2 ratio in the GPB and GNB groups.
Vaccines 10 01648 g004
Figure 5. Schematic image representing increased host inflammatory responses (level of iNOS expression, total nitrite content, NETs release, proinflammatory cytokine level), and organ dysfunction in S. aureus (GPB) infections as compared with E. coli (GNB).
Figure 5. Schematic image representing increased host inflammatory responses (level of iNOS expression, total nitrite content, NETs release, proinflammatory cytokine level), and organ dysfunction in S. aureus (GPB) infections as compared with E. coli (GNB).
Vaccines 10 01648 g005
Table 1. Patient demographic features (mean ± standard deviation).
Table 1. Patient demographic features (mean ± standard deviation).
ParametersValue
Total number of patients60
Age (years)49.11 ± 12.35
Male/female ratio37/23
Body Temperature (°C)38.62 ± 1.28
Heart rate (beats/min)112.45 ± 9.7
Respiratory rate (breaths/min)27.3 ± 4.2
Mean arterial pressure (mm Hg)86.13 ± 13.22
SOFA score7.1 ± 1.23
APACHE II score20.1 ± 4.1
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Gupta, E.; Kumar, S.; Srivastava, V.K.; Saxena, J.; Siddiqui, A.J.; Mehta, S.; Kaushik, S.; Jyoti, A. Unravelling the Differential Host Immuno-Inflammatory Responses to Staphylococcus aureus and Escherichia coli Infections in Sepsis. Vaccines 2022, 10, 1648. https://doi.org/10.3390/vaccines10101648

AMA Style

Gupta E, Kumar S, Srivastava VK, Saxena J, Siddiqui AJ, Mehta S, Kaushik S, Jyoti A. Unravelling the Differential Host Immuno-Inflammatory Responses to Staphylococcus aureus and Escherichia coli Infections in Sepsis. Vaccines. 2022; 10(10):1648. https://doi.org/10.3390/vaccines10101648

Chicago/Turabian Style

Gupta, Ena, Sanni Kumar, Vijay Kumar Srivastava, Juhi Saxena, Arif Jamal Siddiqui, Sudhir Mehta, Sanket Kaushik, and Anupam Jyoti. 2022. "Unravelling the Differential Host Immuno-Inflammatory Responses to Staphylococcus aureus and Escherichia coli Infections in Sepsis" Vaccines 10, no. 10: 1648. https://doi.org/10.3390/vaccines10101648

APA Style

Gupta, E., Kumar, S., Srivastava, V. K., Saxena, J., Siddiqui, A. J., Mehta, S., Kaushik, S., & Jyoti, A. (2022). Unravelling the Differential Host Immuno-Inflammatory Responses to Staphylococcus aureus and Escherichia coli Infections in Sepsis. Vaccines, 10(10), 1648. https://doi.org/10.3390/vaccines10101648

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop